Effect of individual allergen sensitization on omalizumab treatment outcomes in patients with severe allergic asthma determined using data from the Czech Anti-IgE Registry by Petr Vaník, Jakub Novosad, Olga Kirchnerová, Irena Krčmová, Milan Teřl, Czech Anti-IgE Registry collaborators

Subjects: Get full text

Omalizumab for the treatment of patients with severe allergic asthma with immunoglobulin E levels above >1500 IU/mL by Francesco Menzella, MD, Jocelyne Just, MD, PhD, HDR, Inessa Schwab Sauerbeck, PhD, Claudia Mailaender, PhD, Fabiana Saccheri, PhD, Celine Thonnelier, Pharm D, Xavier Jaumont, MD, Laurence Mala, Pharm D

Subjects: Get full text

Real-world effectiveness of omalizumab for severe allergic asthma treatment in Colombia by Carlos A. Torres-Duque, Jaime Ocampo-Gómez, Mauricio Morales Castillo, Diana Cano-Rosales, Ángela Giraldo-Montoya, Freddy Rodríguez, Isabel Palacios-Ortega, Mauricio Durán-Silva, Humberto Reynales, Elizabeth García, REXACOL Consortium

Subjects: Get full text

Omalizumab Treatment in Patients with Severe Allergic Asthma by Tuğba Songül Tat, Aykut Çilli

Subjects: Get full text

Necesidades no cubiertas en asma alérgica grave by Julio Delgado, Ana Navarro, Francisco Javier Álvarez-Gutiérrez, Carolina Cisneros, Javier Domínguez-Ortega

Subjects: “…Severe allergic asthma…”
Get full text

Omalizumab Effectiveness in Severe Allergic Asthma with Multiple Allergic Comorbidities: A Post-Hoc Analysis of the STELLAIR Study by Just J, Thonnelier C, Bourgoin-Heck M, Mala L, Molimard M, Humbert M

Subjects: Get full text

Efficacy and Safety of Omalizumab Treatment Over a 16-Year Follow-Up: When a Clinical Trial Meets Real-Life by Menzella F, Fontana M, Contoli M, Ruggiero P, Galeone C, Capobelli S, Simonazzi A, Catellani C, Scelfo C, Castagnetti C, Livrieri F, Facciolongo N

Subjects: “…severe allergic asthma…”
Get full text

Improvement of patient-reported outcomes in severe allergic asthma by omalizumab treatment: the real life observational PROXIMA study by Giorgio Walter Canonica, Paola Rottoli, Caterina Bucca, Maria Cristina Zappa, Giovanni Michetti, Bruno Macciocchi, Cristiano Caruso, Pierachille Santus, Marta Bartezaghi, Laura Rigoni, on behalf of PROXIMA study centers

Subjects: Get full text

Omalizumab for Severe Allergic Asthma Treatment in Italy: A Cost-Effectiveness Analysis from PROXIMA Study by Canonica GW, Colombo GL, Rogliani P, Santus P, Pitotti C, Di Matteo S, Martinotti C, Bruno GM

Subjects: “…severe allergic asthma…”
Get full text

Gender differences in asthma perception and its impact on quality of life: a post hoc analysis of the PROXIMA (Patient Reported Outcomes and Xolair® In the Management of Asthma) st... by Delia Colombo, Emanuela Zagni, Fabio Ferri, Giorgio Walter Canonica, the PROXIMA study centers

Subjects: Get full text

Efficacy of ABC-X model care intervention combined with omalizumab on moderate to severe allergic asthma and negative emotional of family members by ZHAO Nina, YUE Xueyan, RU Liang

Subjects: Get full text

Health-related quality of life in severe hypersensitivity reactions: focus on severe allergic asthma and hymenoptera venom anaphylaxis—a cross-sectional study by Luisa Ricciardi, Orlando Silvestro, Gabriella Martino, Antonino Catalano, Carmelo Mario Vicario, Trine Lund-Jacobsen, Peter Schwarz, Daniela Sapienza, Sebastiano Gangemi, Giovanni Pioggia, Concetto Mario Giorgianni

Subjects: Get full text